Journal articles on the topic 'Neuromuscular function'

To see the other types of publications on this topic, follow the link: Neuromuscular function.

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Neuromuscular function.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Beemer, G. H., and P. Rozental. "Postoperative Neuromuscular Function." Anaesthesia and Intensive Care 14, no. 1 (February 1986): 41–45. http://dx.doi.org/10.1177/0310057x8601400110.

Full text
Abstract:
One hundred patients who received a competitive neuromuscular blocking agent during anaesthesia were randomly selected for evaluation of neuromuscular function immediately on their arrival in the recovery room. The anaesthetist was not aware that the patient would be evaluated in the recovery room. Neuromuscular function was assessed by a train-of-four (TOF) ratio, and in conscious and co-operative patients by a series of bedside tests of neuromuscular function. Twenty-one patients had a TOF ratio of less than 0.70 and seven patients a TOF ratio of less than 0.60. Bedside tests of neuromuscular function did not reliably detect this defect in neuromuscular transmission. It is concluded that a relatively large number of patients have a defect in neuromuscular transmission on their arrival in the recovery room, and suggested that this reflects the inadequacy of clinical methods used for the administration and antagonism of competitive neuromuscular blocking agents at this institution.
APA, Harvard, Vancouver, ISO, and other styles
2

Ortega, Rafael, Sorin J. Brull, Richard Prielipp, Alexander Gutierrez, Rossemary De La Cruz, and Christopher M. Conley. "Monitoring Neuromuscular Function." New England Journal of Medicine 378, no. 4 (January 25, 2018): e6. http://dx.doi.org/10.1056/nejmvcm1603741.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Suh, Jae Hyeun. "Neuromuscular Function Monitoring." Korean Journal of Anesthesiology 24, no. 2 (1991): 219. http://dx.doi.org/10.4097/kjae.1991.24.2.219.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Engbaek, J. "Monitoring neuromuscular function." Current Opinion in Anaesthesiology 2, no. 4 (August 1989): 479–83. http://dx.doi.org/10.1097/00001503-198908000-00020.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Kopman, Aaron F. "Monitoring Neuromuscular Function." ASA Refresher Courses in Anesthesiology 39, no. 1 (2011): 72–79. http://dx.doi.org/10.1097/asa.0b013e3182284668.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Monti, Elizabeth J., Mary E. Kerr, and Catherine Bender. "Monitoring Neuromuscular Function." Journal of Neuroscience Nursing 27, no. 4 (August 1995): 252–57. http://dx.doi.org/10.1097/01376517-199508000-00011.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

ALI, HASSAN H. "Monitoring Neuromuscular Function." Anesthesiology 64, no. 4 (April 1, 1986): 532. http://dx.doi.org/10.1097/00000542-198604000-00034.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

KOPMAN, AARON F. "Monitoring Neuromuscular Function." Anesthesiology 64, no. 4 (April 1, 1986): 532. http://dx.doi.org/10.1097/00000542-198604000-00035.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Feldman, Stanley A., and Adrian J. England. "Neuromuscular function and block." Current Opinion in Anaesthesiology 8, no. 4 (August 1995): 351–55. http://dx.doi.org/10.1097/00001503-199508000-00015.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Wareham, Anthony C. "Neuromuscular function and transmission." Anaesthesia & Intensive Care Medicine 6, no. 6 (June 2005): 203–5. http://dx.doi.org/10.1383/anes.6.6.203.65787.

Full text
APA, Harvard, Vancouver, ISO, and other styles
11

Racinais, S., and J. Oksa. "Temperature and neuromuscular function." Scandinavian Journal of Medicine & Science in Sports 20 (October 4, 2010): 1–18. http://dx.doi.org/10.1111/j.1600-0838.2010.01204.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
12

Newton, Douglas E. F. "Measurement of neuromuscular function." Baillière's Clinical Anaesthesiology 2, no. 1 (March 1988): 133–56. http://dx.doi.org/10.1016/s0950-3501(88)80026-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
13

Fletcher, Allan. "Neuromuscular function and transmission." Anaesthesia & Intensive Care Medicine 9, no. 6 (June 2008): 256–58. http://dx.doi.org/10.1016/j.mpaic.2008.04.005.

Full text
APA, Harvard, Vancouver, ISO, and other styles
14

Fletcher, Allan. "Neuromuscular function and transmission." Anaesthesia & Intensive Care Medicine 12, no. 6 (June 2011): 245–48. http://dx.doi.org/10.1016/j.mpaic.2011.03.012.

Full text
APA, Harvard, Vancouver, ISO, and other styles
15

Ali, Hassan H. "Monitoring of neuromuscular function." International Journal of Clinical Monitoring and Computing 4, no. 3 (September 1987): 185–89. http://dx.doi.org/10.1007/bf02915906.

Full text
APA, Harvard, Vancouver, ISO, and other styles
16

Mouta, Pedro Andrade, Nuno Edgar Carones Esteves, Carina Manuela Peralta de Oliveira, and Patricia Andreia Santos Cardoso. "Monitorização por train of four (TOF) na titulação de fármacos bloqueadores da função neuromuscular: revisão sistemática da literatura." Revista Recien - Revista Científica de Enfermagem 13, no. 41 (July 11, 2023): 523–31. http://dx.doi.org/10.24276/rrecien2023.13.41.523-531.

Full text
Abstract:
A utilização de fármacos bloqueadores da função neuromuscular é uma prática frequente nos serviços de saúde com doentes em estado crítico, sendo necessário um conhecimento profundo dos efeitos adversos da sua utilização para poder minimizá-los. Propusemo-nos a investigar de que forma a monitorização do grau de bloqueio neuromuscular, com recurso ao train of four (TOF) permite uma melhor titulação dos fármacos e consequente diminuição dos seus efeitos adversos. Realizou-se uma revisão sistemática da literatura publicada entre 1995 e 2022 nas bases de dados: Medline, CINAHL, MedicLatina e Academic Search Complete, utilizando os descritores MeSh “nurs*”, “intensive care unit”, “icu”, “critical care”, “critical care unit”, “neuromuscular blockade” e "electric stimulation". Os resultados demonstram uma divergência de achados, no entanto, a monitorização por TOF permite uma medida objetiva de avaliação do grau de bloqueio neuromuscular e, consequentemente, uma melhor titulação dos fármacos bloqueadores da função neuromuscular. Descritores: Enfermeiro, ICU, Bloqueadores Neuromusculares, Train of Four. Monitoring by train of four (TOF) on drug titration blocking neuromuscular function: systematic review of the literature Abstract: The use of neuromuscular function blocking drugs is a frequent practice in health services with critically ill patients, and a deep knowledge of the adverse effects of their use is necessary in order to minimize them. We propose to investigate how the monitoring of the degree of neuromuscular blockade, using the train of four (TOF), allows a better titration of drugs and consequent reduction of their adverse effects. A systematic review of the literature published between 1995 and 2022 was conducted in the following databases: Medline, CINAHL, MedicLatina and Academic Search Complete, using the descriptors MeSh "nurs*", "intensive care unit", "icu", "critical care", "critical care unit", "neuromuscular blockade" and "electric stimulation". The results demonstrate a divergence of findings, however, TOF monitoring allows an objective measure of evaluation of the degree of neuromuscular blockade and, consequently, a better titration of neuromuscular function blocking drugs. Descriptors: Nurse, ICU, Neuromuscular Blocking Agents, Train of Four. Monitorización del tren de cuatro (TOF) en la titulación de fármacos bloqueantes de la función neuromuscular: revisión sistemática de la literatura Resumen: El uso de fármacos bloqueadores de la función neuromuscular es una práctica frecuente en los servicios de salud con pacientes críticos, y es necesario un conocimiento profundo de los efectos adversos de su uso para minimizarlos. Proponemos investigar cómo la monitorización del grado de bloqueo neuromuscular, utilizando el tren de cuatro (TOF) permite una mejor titulación de los fármacos y la consiguiente reducción de sus efectos adversos. Se realizó una revisión sistemática de la literatura publicada entre 1995 y 2022 en las siguientes bases de datos: Medline, CINAHL, MedicLatina y Academic Search Complete, utilizando los descriptores MeSh "nurs*", "intensive care unit", "icu", "critical care", "critical care unit", "neuromuscular blockade" y "electric stimulation". Los resultados demuestran una divergencia de hallazgos, sin embargo, la monitorización permite una medida objetiva de evaluación del grado de bloqueo neuromuscular y, en consecuencia, una mejor titulación de los fármacos bloqueadores de la función neuromuscular. Descriptores: Enfermera, UCI, Bloqueadores Neuromusculares, Tren de Cuatro.
APA, Harvard, Vancouver, ISO, and other styles
17

Agre, James C., and Arthur A. Rodriquez. "NEUROMUSCULAR FUNCTION IN POLIO SURVIVORS." Orthopedics 14, no. 12 (December 1991): 1343–47. http://dx.doi.org/10.3928/0147-7447-19911201-09.

Full text
APA, Harvard, Vancouver, ISO, and other styles
18

Valero-Cuevas, F. J., H. Hoffmann, M. U. Kurse, J. J. Kutch, and E. A. Theodorou. "Computational Models for Neuromuscular Function." IEEE Reviews in Biomedical Engineering 2 (2009): 110–35. http://dx.doi.org/10.1109/rbme.2009.2034981.

Full text
APA, Harvard, Vancouver, ISO, and other styles
19

Parkman, Henry P., and Michael P. Jones. "Tests of Gastric Neuromuscular Function." Gastroenterology 136, no. 5 (May 2009): 1526–43. http://dx.doi.org/10.1053/j.gastro.2009.02.039.

Full text
APA, Harvard, Vancouver, ISO, and other styles
20

Langford, R. "iPhone for monitoring neuromuscular function." Anaesthesia 67, no. 5 (April 11, 2012): 552–53. http://dx.doi.org/10.1111/j.1365-2044.2012.07094_2.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
21

Bolton, Charles. "Neuromuscular function in the I.C.U." Acta Anaesthesiologica Scandinavica 41, S110 (June 1997): 109–12. http://dx.doi.org/10.1111/j.1399-6576.1997.tb05522.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
22

FORRESTER, S. E., S. J. ALLEN, R. G. PRESSWOOD, A. C. TOY, and M. T. G. PAIN. "Neuromuscular function in healthy occlusion." Journal of Oral Rehabilitation 37, no. 9 (August 15, 2010): 663–69. http://dx.doi.org/10.1111/j.1365-2842.2010.02097.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
23

Kopman, Aaron F. "Postanesthesia Evaluation of Neuromuscular Function." Anesthesiology 119, no. 3 (September 1, 2013): 729. http://dx.doi.org/10.1097/aln.0b013e31829ff1f3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
24

Simpson, David M., David A. Katzenstein, Michael D. Hughes, Scott M. Hammer, Diana L. Williamson, Qi Jiang, and Ju-Tsung Pi. "Neuromuscular function in HIV infection." AIDS 12, no. 18 (December 1998): 2425–32. http://dx.doi.org/10.1097/00002030-199818000-00011.

Full text
APA, Harvard, Vancouver, ISO, and other styles
25

Stanec, A., I. Nacino, and T. Baker. "ROUTINE MONITORING OF NEUROMUSCULAR FUNCTION." Anesthesia & Analgesia 67, Supplement (February 1988): 217. http://dx.doi.org/10.1213/00000539-198802001-00217.

Full text
APA, Harvard, Vancouver, ISO, and other styles
26

Gulbransen, Brian D. "Emerging tools to study enteric neuromuscular function." American Journal of Physiology-Gastrointestinal and Liver Physiology 312, no. 5 (May 1, 2017): G420—G426. http://dx.doi.org/10.1152/ajpgi.00049.2017.

Full text
Abstract:
Investigating enteric neuromuscular function poses specific challenges that are not encountered in other systems. The gut has a complex cellular composition, and methods to study diverse multicellular interactions during physiological gut functions have been limited. However, new technologies are emerging in optics, genetics, and bioengineering that greatly expand the capabilities to study integrative functions in the gut. In this mini-review, I discuss several areas where the application of these technologies could benefit ongoing efforts to understand enteric neuromuscular function. I specifically focus on technologies that can be applied to study specific cellular networks and the mechanisms that link activity to function.
APA, Harvard, Vancouver, ISO, and other styles
27

Viby-Mogensen, J., and C. Claudius. "Recovery from neuromuscular blockade and routine monitoring of neuromuscular function." Anaesthesia 62, no. 12 (November 5, 2007): 1292–94. http://dx.doi.org/10.1111/j.1365-2044.2007.05359_1.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
28

Dorsey, Susan G., Richard M. Lovering, Cynthia L. Renn, Carmen C. Leitch, Xinyue Liu, Luke J. Tallon, Lisa DeShong Sadzewicz, et al. "Genetic deletion of trkB.T1 increases neuromuscular function." American Journal of Physiology-Cell Physiology 302, no. 1 (January 2012): C141—C153. http://dx.doi.org/10.1152/ajpcell.00469.2010.

Full text
Abstract:
Neurotrophin-dependent activation of the tyrosine kinase receptor trkB.FL modulates neuromuscular synapse maintenance and function; however, it is unclear what role the alternative splice variant, truncated trkB ( trkB.T1), may have in the peripheral neuromuscular axis. We examined this question in trkB.T1 null mice and demonstrate that in vivo neuromuscular performance and nerve-evoked muscle tension are significantly increased. In vitro assays indicated that the gain-in-function in trkB.T1 −/− animals resulted specifically from an increased muscle contractility, and increased electrically evoked calcium release. In the trkB.T1 null muscle, we identified an increase in Akt activation in resting muscle as well as a significant increase in trkB.FL and Akt activation in response to contractile activity. On the basis of these findings, we conclude that the trkB signaling pathway might represent a novel target for intervention across diseases characterized by deficits in neuromuscular function.
APA, Harvard, Vancouver, ISO, and other styles
29

Suzuki, Takahiro. "Muscle Relaxants -Masterly Manipulates Neuromuscular Function." Journal of Nihon University Medical Association 72, no. 1 (2013): 61–63. http://dx.doi.org/10.4264/numa.72.61.

Full text
APA, Harvard, Vancouver, ISO, and other styles
30

van den Maagdenberg, AMJM, and JJ Plomp. "Neuromuscular Synapse Function in Typical Migraine." Cephalalgia 23, no. 2 (March 2003): 73–74. http://dx.doi.org/10.1046/j.1468-2982.2003.00501.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
31

Belanger, A. Y., and A. J. McComas. "Neuromuscular function in limb girdle dystrophy." Journal of Neurology, Neurosurgery & Psychiatry 48, no. 12 (December 1, 1985): 1253–58. http://dx.doi.org/10.1136/jnnp.48.12.1253.

Full text
APA, Harvard, Vancouver, ISO, and other styles
32

Young, Nwanmegha, Mikhail Wadie, and Clarence T. Sasaki. "Neuromuscular Basis for Ventricular Fold Function." Annals of Otology, Rhinology & Laryngology 121, no. 5 (May 2012): 317–21. http://dx.doi.org/10.1177/000348941212100506.

Full text
APA, Harvard, Vancouver, ISO, and other styles
33

Girard, Olivier, Jean-Paul Micallef, Julien Noual, and Grégoire P. Millet. "Alteration of neuromuscular function in squash." Journal of Science and Medicine in Sport 13, no. 1 (January 2010): 172–77. http://dx.doi.org/10.1016/j.jsams.2008.11.002.

Full text
APA, Harvard, Vancouver, ISO, and other styles
34

Kalmar, J. M., and E. Cafarelli. "Effects of caffeine on neuromuscular function." Journal of Applied Physiology 87, no. 2 (August 1, 1999): 801–8. http://dx.doi.org/10.1152/jappl.1999.87.2.801.

Full text
Abstract:
This double-blind, repeated-measures study examined the effects of caffeine on neuromuscular function. Eleven male volunteers [22.3 ± 2.4 (SD) yr] came to the laboratory for control, placebo, and caffeine (6 mg/kg dose) trials. Each trial consisted of 10 × 1-ms stimulation of the tibial nerve to elicit maximal H reflexes of the soleus, four attempts at a maximal voluntary contraction (MVC) of the right knee extensors, six brief submaximal contractions, and a 50% MVC held to fatigue. Isometric force and surface electromyographic signals were recorded continuously. The degree of maximal voluntary activation was assessed with the twitch-interpolation technique. Single-unit recordings were made with tungsten microelectrodes during the submaximal contractions. Voluntary activation at MVC increased by 3.50 ± 1.01 (SE) % ( P < 0.01), but there was no change in H-reflex amplitude, suggesting that caffeine increases maximal voluntary activation at a supraspinal level. Neither the force-EMG relationship nor motor unit firing rates were altered by caffeine. Subjects were able to hold a 50% MVC for an average of 66.1 s in the absence of caffeine. Time to fatigue (Tlim) increased by 25.80 ± 16.06% after caffeine administration ( P < 0.05). There was no significant change in Tlim from pretest to posttest in the control or placebo trials. The increase in Tlim was associated with an attenuated decline in twitch amplitude, which would suggest that the mechanism is, at least in part, peripheral.
APA, Harvard, Vancouver, ISO, and other styles
35

Courtney, Carol A., Michael A. O’Hearn, and T. George Hornby. "Neuromuscular Function in Painful Knee Osteoarthritis." Current Pain and Headache Reports 16, no. 6 (September 29, 2012): 518–24. http://dx.doi.org/10.1007/s11916-012-0299-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
36

Bhakta, Deepak, and William J. Groh. "Cardiac function tests in neuromuscular diseases." Neurologic Clinics 22, no. 3 (August 2004): 591–617. http://dx.doi.org/10.1016/j.ncl.2004.03.001.

Full text
APA, Harvard, Vancouver, ISO, and other styles
37

ESTANISLAO, L., D. THOMAS, and D. SIMPSON. "HIV neuromuscular disease and mitochondrial function." Mitochondrion 4, no. 2-3 (July 2004): 131–39. http://dx.doi.org/10.1016/j.mito.2004.06.007.

Full text
APA, Harvard, Vancouver, ISO, and other styles
38

Ward, Nicholas S., and Nicholas S. Hill. "Pulmonary Function Testing in Neuromuscular Disease." Clinics in Chest Medicine 22, no. 4 (December 2001): 769–81. http://dx.doi.org/10.1016/s0272-5231(05)70065-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
39

Berke, Gerald S., Keith E. Blackwell, and Roger Crumley. "Selective modification of laryngeal neuromuscular function." Operative Techniques in Otolaryngology-Head and Neck Surgery 10, no. 1 (March 1999): 2–5. http://dx.doi.org/10.1016/s1043-1810(99)80041-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
40

Sharma, Girish D. "Pulmonary Function Testing in Neuromuscular Disorders." Pediatrics 123, Supplement 4 (May 2009): S219—S221. http://dx.doi.org/10.1542/peds.2008-2952d.

Full text
APA, Harvard, Vancouver, ISO, and other styles
41

Jones, C. Stanley. "Indicators of Recovery of Neuromuscular Function." Anesthesiology 87, no. 6 (December 1, 1997): 1595. http://dx.doi.org/10.1097/00000542-199712000-00058.

Full text
APA, Harvard, Vancouver, ISO, and other styles
42

Kopman, Aaron F., Pamela S. Yee, and George G. Neuman. "Indicators of Recovery of Neuromuscular Function." Anesthesiology 87, no. 6 (December 1, 1997): 1595. http://dx.doi.org/10.1097/00000542-199712000-00059.

Full text
APA, Harvard, Vancouver, ISO, and other styles
43

Brull, Sorin J. "Indicators of Recovery of Neuromuscular Function." Anesthesiology 86, no. 4 (April 1, 1997): 755–57. http://dx.doi.org/10.1097/00000542-199704000-00001.

Full text
APA, Harvard, Vancouver, ISO, and other styles
44

Glatthorn, Julia F., Andreas M. Berendts, Mario Bizzini, Urs Munzinger, and Nicola A. Maffiuletti. "Neuromuscular Function after Arthroscopic Partial Meniscectomy." Clinical Orthopaedics and Related Research® 468, no. 5 (November 21, 2009): 1336–43. http://dx.doi.org/10.1007/s11999-009-1172-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
45

Tintignac, Lionel A., Hans-Rudolf Brenner, and Markus A. Rüegg. "Mechanisms Regulating Neuromuscular Junction Development and Function and Causes of Muscle Wasting." Physiological Reviews 95, no. 3 (July 2015): 809–52. http://dx.doi.org/10.1152/physrev.00033.2014.

Full text
Abstract:
The neuromuscular junction is the chemical synapse between motor neurons and skeletal muscle fibers. It is designed to reliably convert the action potential from the presynaptic motor neuron into the contraction of the postsynaptic muscle fiber. Diseases that affect the neuromuscular junction may cause failure of this conversion and result in loss of ambulation and respiration. The loss of motor input also causes muscle wasting as muscle mass is constantly adapted to contractile needs by the balancing of protein synthesis and protein degradation. Finally, neuromuscular activity and muscle mass have a major impact on metabolic properties of the organisms. This review discusses the mechanisms involved in the development and maintenance of the neuromuscular junction, the consequences of and the mechanisms involved in its dysfunction, and its role in maintaining muscle mass during aging. As life expectancy is increasing, loss of muscle mass during aging, called sarcopenia, has emerged as a field of high medical need. Interestingly, aging is also accompanied by structural changes at the neuromuscular junction, suggesting that the mechanisms involved in neuromuscular junction maintenance might be disturbed during aging. In addition, there is now evidence that behavioral paradigms and signaling pathways that are involved in longevity also affect neuromuscular junction stability and sarcopenia.
APA, Harvard, Vancouver, ISO, and other styles
46

Donnelly, Chris, Timothée Popesco, Julie Rossé, Bengt Kayser, Nicola A. Maffiuletti, and Nicolas Place. "Acute Effects of Neuromuscular Electrical Stimulation on Contralateral Plantar Flexor Neuromuscular Function." Biology 11, no. 11 (November 12, 2022): 1655. http://dx.doi.org/10.3390/biology11111655.

Full text
Abstract:
Contralateral facilitation, i.e., the increase in contralateral maximal voluntary strength that is observed when neuromuscular electrical stimulation (NMES) is applied to the ipsilateral homonymous muscle, has previously been reported for the knee extensors but the neurophysiological mechanisms remain to be investigated. The aim of this study was to compare plantar flexor contralateral facilitation between a submaximal voluntary contraction (~10% MVC torque) and two evoked contractions (conventional and wide-pulse high-frequency NMES) of the ipsilateral plantar flexors, with respect to a resting condition. Contralateral MVC torque and voluntary activation level were measured in 22 healthy participants while the ipsilateral plantar flexors were at rest, voluntarily contracted or stimulated for 15 s. Additional neurophysiological parameters (soleus H-reflex and V-wave amplitude and tibialis anterior coactivation level) were quantified in a subgroup of 12 participants. Conventional and wide-pulse high-frequency NMES of the ipsilateral plantar flexors did not induce any contralateral facilitation of maximal voluntary strength and activation with respect to the resting condition. Similarly, no alteration of neurophysiological parameters was observed in the different conditions. This absence of contralateral facilitation contrasts with some results previously obtained on the knee extensors but is consistent with the absence of neurophysiological changes on the contralateral soleus.
APA, Harvard, Vancouver, ISO, and other styles
47

Popesco, Timothée, Chris Donnelly, Julie Rosse, Bengt Kayser, Nicolas A. Maffiuletti, and Nicolas Place. "Acute effects of neuromuscular electrical stimulation on contralateral plantar flexor neuromuscular function." Current Issues in Sport Science (CISS) 8, no. 2 (February 14, 2023): 018. http://dx.doi.org/10.36950/2023.2ciss018.

Full text
Abstract:
Introduction Neuromuscular electrical stimulation (NMES) is used in athletes to enhance muscle strength (Filipovic et al., 2012) or in patients to restore muscle strength (Nussbaum et al., 2017). The increased maximal voluntary contraction (MVC) torque of one limb (e.g. right leg) while transcutaneous NMES is concomitantly applied to the contralateral limb (e.g. left leg) has been termed contralateral facilitation. This effect has previously been reported for the knee extensors (Cattagni et al., 2018; Minetto et al., 2018) but the underlying mechanisms remain to be investigated. It is also not known whether or not other muscle groups may show contralateral facilitation. The aim of this study was to compare plantar flexor contralateral facilitation between a submaximal voluntary contraction (~10% MVC torque) and two evoked contractions with presumably distinct motor unit recruitment patterns (conventional and wide-pulse high-frequency [WPHF] NMES; Bergquist et al., 2011) of the ipsilateral plantar flexors, with respect to a resting condition. Methods Twenty-two healthy volunteers (4 women: mean ± SD, 26 ±4 yrs, 162 ±7 cm, 65 ±9 kg and 18 men: 26 ±6 yrs, 180 ±5 cm, 76 ±6 kg) took part to the experiments. Contralateral MVC torque and maximal voluntary activation level were measured in 4 different conditions: while the ipsilateral plantar flexors were at rest, voluntarily contracted at 10% of MVC torque or stimulated with conventional (0.1 ms, 30 Hz) and wide-pulse high frequency (1 ms, 100 Hz) NMES for 15 s at a pre-determined intensity to evoke 10% of MVC torque. Additional neurophysiological parameters (soleus H-reflex and V-wave amplitude and tibialis anterior coactivation level) were quantified in a subgroup of 12 participants (4 women and 8 men). Results Conventional and WPHF NMES of the ipsilateral plantar flexors did not induce any contralateral facilitation of MVC torque with respect to the resting condition (respectively: mean ± SD, 133 ±44, 133 ±43 and 135 ±39 Nm) as well as maximal voluntary activation level, while an ipsilateral voluntary contraction of the same intensity resulted in lower contralateral strength than conventional NMES. Moreover, no alteration in the neurophysiological parameters was observed in the different conditions. Discussion/Conclusion The absence of contralateral facilitation contrasts with the results obtained on the knee extensors and can be attributed to the absence of neural changes observed on the contralateral side. These findings should be considered by clinicians/researchers in lower limb rehabilitation settings, as it seems easier to induce contralateral facilitation in proximal vs. distal lower limbs. References Bergquist, A. J., Clair, J. M., Lagerquist, O., Mang, C. S., Okuma, Y., & Collins, D. F. (2011). Neuromuscular electrical stimulation: Implications of the electrically evoked sensory volley. European Journal of Applied Physiology, 111, 2409–2426. https://doi.org/10.1007/s00421-011-2087-9 Cattagni, T., Lepers, R., & Maffiuletti, N. A. (2018). Effects of neuromuscular electrical stimulation on contralateral quadriceps function. Journal of Electromyography and Kinesiology, 38, 111-118. https://doi.org/10.1016/j.jelekin.2017.11.013 Filipovic, A., Kleinöder, H., Dörmann, U., & Mester, J. (2012). Electromyostimulation: A systematic review of the effects of different electromyostimulation methods on selected strength parameters in trained and elite athletes. Journal of Strength and Conditioning Research, 26(9), 2600-2614. https://doi.org/10.1519/JSC.0b013e31823f2cd1 Minetto, M., Botter, A., Gamerro, G., Varvello, I., Massazza, G., Bellomo, R., Maffiuletti, N., & Saggini, R. (2018). Contralateral effect of short-duration unilateral neuromuscular electrical stimulation and focal vibration in healthy subjects. European Journal of Physical and Rehabilitation Medicine, 54(6), 911-920. Nussbaum, E., Houghton, P., Anthony, J., Rennie, S., Shay, B., & Hoens, A. (2017). Neuromuscular electrical stimulation for treatment of muscle impairment: Critical review and recommendations for clinical practice. Physiotherapy Canada, 69(5), 1-76. https://doi.org/10.3138/ptc.2015-88
APA, Harvard, Vancouver, ISO, and other styles
48

Kumar, Gopalaiah Venkatesh, Anita Pramod Nair, Hanuman Srinivasa Murthy, Koppa Ramegowda Jalaja, Karnate Ramachandra, and Gundappa Parameshwara. "Residual Neuromuscular Blockade Affects Postoperative Pulmonary Function." Anesthesiology 117, no. 6 (December 1, 2012): 1234–44. http://dx.doi.org/10.1097/aln.0b013e3182715b80.

Full text
Abstract:
Abstract Background Residual neuromuscular blockade (RNMB) is known to be associated with respiratory complications in the postoperative period after muscle relaxant usage. The authors hypothesized that RNMB causes reductions in pulmonary function test (PFT) parameters in the immediate postoperative period. Methods An open-label prospective randomized cohort study was conducted comparing reductions in PFT parameters due to RNMB among different neuromuscular blocking agents. One hundred and fifty patients were randomized to receive vecuronium, atracurium, or rocuronium. After reversal of neuromuscular blockade and extubation, train-of-four ratio was measured every 5 min until the train-of-four ratio of 0.9 or greater was attained. PFTs were performed preoperatively and postoperatively when the patients were willing and fit. The train-of-four ratio, measured at PFT, was used to classify patients into “RNMB absent” and “RNMB present.” RNMB was defined as a train-of-four ratio less than 0.9. Results Thirty-nine patients had RNMB at the time of performing PFT. There was no statistically significant difference in the postoperative reductions in PFT parameters in patients with RNMB among different neuromuscular blocking agents. Patients were regrouped as RNMB absent and RNMB present, irrespective of neuromuscular blocking agents. Postoperative PFT values for the RNMB-absent and RNMB-present groups were 62% and 49% of baseline forced vital capacity and 47% and 38% of baseline peak expiratory flow of the baseline, respectively. Postoperative forced vital capacity and peak expiratory flow values of RNMB-present patients were lower by 13% and 9% in absolute terms (P &lt; 0.008) and 21% and 19% in relative terms, respectively, compared with RNMB-absent patients. Conclusion RNMB results in reductions in forced vital capacity and peak expiratory flow in the immediate postoperative period indicating impaired respiratory muscle function.
APA, Harvard, Vancouver, ISO, and other styles
49

Geurts, Carla L. M. "Effect of cold acclimation on neuromuscular function of the hand." Applied Physiology, Nutrition, and Metabolism 31, no. 4 (August 2006): 480–81. http://dx.doi.org/10.1139/h06-013.

Full text
Abstract:
The research in this thesis investigated the effects of cold stress on neuromuscular function with the main focus on cold acclimation. In total, 6 studies, 1 field study and 5 experiments, were conducted. The field study showed that during manual work in cold weather, finger and hand temperature can drop to levels that may impair manual function. The first 2 experiments were conducted to investigate the effect of acute local cold stress on force control and to investigate the effect of cold-induced vasodilatation (CIVD) on neuromuscular function. In experiment 1, it was found that cooling of the hand in 10 °C cold water for 10 min did not improve force control, although neuromuscular function was significantly impaired after cooling. In experiment 2, cold-induced vasodilatation, occurring after 20 min of 8 °C cold-water immersion of the hand, was confined to the finger tip and had no effect on the temperature of the first dorsal interosseus (FDI) muscle or its neuromuscular function. A series of cold acclimation studies was conducted to investigate the effect of repeated cold-water hand immersions on neuromuscular function. In these experiments, neuromuscular function was tested before and after 2–3 weeks of daily hand immersion in 8 °C cold water for 30 min. In experiment 3, it was found that 3 weeks of cold-water immersion resulted in a decrease in minimum and mean index finger temperature and CIVD was attenuated. Neuromuscular function was not affected by this change in temperature response. In experiment 4, one hand was exposed daily to cold water and compared with the opposite control hand. Blood plasma catecholamine concentrations were increased after 2 weeks in the cold-exposed hand, but no changes in temperature response or neuromuscular function were found after repeated cold exposure. Thermal comfort after 30 min of cold-water immersion significantly improved after repeated cold exposure causing a discrepancy between actual and perceived temperature and it was suggested that this may impose a greater risk of cold injury owing to a change in behavioural thermoregulation. In the last experiment, core temperature was elevated by bicycling at a submaximal level during the cold hand immersion. Exercise had a direct effect on the temperature response during cold-water immersion, decreasing the minimum FDI temperature and slowing down the deteriorating effect of cold on neuromuscular function; however, exercise showed was no effect on local cold acclimation. It is concluded that local repeated cold exposures may improve finger and hand temperature and subjective thermal ratings, but that these changes are too small to improve neuromuscular function. The best remedy to maintain manual function is to limit or avoid cold stress as much as possible. If sufficient protection of the hands is impossible, core heating through exercise or passive heating may be a solution.
APA, Harvard, Vancouver, ISO, and other styles
50

Duddy, William J., and Stephanie Duguez. "Understanding Neuromuscular Health and Disease: Advances in Genetics, Omics, and Molecular Function." Journal of Personalized Medicine 11, no. 5 (May 20, 2021): 438. http://dx.doi.org/10.3390/jpm11050438.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography